Nuro secures $6 billion valuation in latest funding round - Reuters
3 weeks ago • Google News
NeuroMetrix Inc (NURO)
US$ 3.72-2.87%
Price Chart
Key Statistics
Market Cap
$ 9.01M
P/E Ratio
0.00
Revenue (TTM)
$ 3.03M
Volume
19.87K
52W High
$ 4.73
52W Low
$ 2.66
Dividend Yield
0.00%
Beta
1.83
Technicals
50-Day MA
4.3984
200-Day MA
4.04
52 Week High
4.73
52 Week Low
2.66
About NURO
NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic pu.
Employees
13
Headquarters
Woburn, MA
CEO
Dr. Shai N. Gozani M.D., Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg